Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hypolipidaemic agents (author's transl)]

J P Tillement, E Albengres, H Choisy

    La Nouvelle Presse Medicale
    |October 30, 1980
    PubMed
    Summary
    This summary is machine-generated.

    This paper reviews pharmacological and therapeutic properties of hyperlipoproteinaemia treatments developed since clofibrate. It also discusses compounds like probucol currently in clinical studies.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Infusion of docosahexaenoic acid protects against myocardial infarction.

    Prostaglandins, leukotrienes, and essential fatty acids·2014
    Same author

    Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.

    British journal of clinical pharmacology·2004
    Same author

    Evidence for resveratrol-induced preservation of brain mitochondria functions after hypoxia-reoxygenation.

    Drugs under experimental and clinical research·2004
    Same author

    Paediatric methylphenidate (Ritalin) restrictive conditions of prescription in France.

    British journal of clinical pharmacology·2003
    Same author

    [Development of antidepressant drugs. Experience and prospects].

    Presse medicale (Paris, France : 1983)·2003
    Same author

    Bromism from daily over intake of bromide salt.

    Journal of toxicology. Clinical toxicology·2003

    Area of Science:

    • Pharmacology
    • Therapeutics
    • Drug Discovery

    Context:

    • Hyperlipoproteinaemia treatment landscape evolution
    • Post-clofibrate era drug development
    • Emerging therapies for lipid disorders

    Purpose:

    • Summarize pharmacological and therapeutic properties of existing hyperlipoproteinaemia treatments
    • Review compounds in pre-clinical and clinical studies
    • Highlight advancements in lipid-lowering drug development

    Summary:

    • Overview of established hyperlipoproteinaemia medications
    • Discussion of drug mechanisms and efficacy
    • Introduction to novel agents like probucol

    Impact:

    • Informs clinicians on current treatment options
    • Guides researchers on future drug development
    • Contributes to the understanding of lipid metabolism and management